Home » Topics » Disease categories and therapies » Musculoskeletal

Musculoskeletal
RSS

Mice homozygous for LGMD2I-causing FKRP mutation show progressive myopathy

Jan. 8, 2016

Novel preclinical model for cancer cachexia

Dec. 30, 2015

PI3Kdelta inhibitors revealed in Merck & Co. patent

Dec. 29, 2015

Biosimilar adalimumab M-923 met primary endpoint in pharmacokinetic study

Dec. 24, 2015

Cell therapy improves functional and structural outcome after muscle trauma

Dec. 23, 2015

Galapagos and Gilead Sciences partner to develop filgotinib for inflammatory diseases

Dec. 17, 2015

TEI-SARM2 shows promise for the treatment of muscle wasting diseases

Dec. 11, 2015

FDA decides to review Anika's Cingal as drug rather than device

Dec. 11, 2015

Morphotek reports phase I data from MORAb-022-001 trial

Dec. 11, 2015

Novartis initiates first-in-human trial of LNA-043

Dec. 11, 2015

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 2, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 30, 2026
Deep brain stimulation from the shallows: tomorrow’s BCI technology?
BioWorld
Deep brain stimulation (DBS) through implanted electrodes has enabled fundamentally new ways of treating certain disorders. More than 100,000 severely ill...
CINP 2026: organoids reveal autism and addiction mechanisms
BioWorld Science
At the 2026 World Congress of Neuropsychopharmacology (CINP), held in Glasgow June 26-29, 2026, researchers from Japan’s National Center of Neurology and...
Deerfield-backed Boulevard, Metis pen $1.6B trispecific TCE deal
BioWorld
A U.S. biotechnology company founded by Deerfield Management Company L.P. licensed exclusive rights to Metis Techbio Co. Ltd.’s preclinical trispecific T-cell...